LNSR LENSAR, Inc.

NASDAQ
$8.20

LENSAR, Inc. (LNSR) is expected to report earnings on November 12, 2026, before the market open.

LENSAR Reported Earnings
Thursday, August 13, 2026 · 7:00 AM ET
Earnings Date
Nov 12
Thursday · 7:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About LENSAR, Inc.

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Sector

Healthcare

Held By 1 ETFs, by dollar flow